Cell detachment ratio on pH-responsive chitosan : A useful biometric for prognostic judgment and drug efficacy assessment in oncology
Copyright © 2021 Elsevier Ltd. All rights reserved..
The inherently unpredictable complexity of tumors impedes the widespread practice of the molecular biomarkers in outcome prediction. Alternatively, from the biophysical perspective, this study sought to investigate the applicability of the cell detachment ratio (CDR) derived from pH-responsive chitosan as a biometrical identifier for the disease state in cancer prognostic judgment and drug efficacy assessment. In the targeted therapy model, the repression of tumor dissemination in cells harboring aberrant ErbB signals (human non-small cell lung cancer cell line PC9 and breast cancer cell line BT474) were first demonstrated both in vitro and in vivo. Consequently, the corresponding CDR profile goes synchronously with the extent of cancer regression in response to the medication. Definitive integrins that drive the cell detachment were also verified through CDR examination following the integrin functional blockade. Conclusively, CDR is a promising clinical index for evaluation of the metastatic cell behaviors in terms of the cell detachment.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:261 |
---|---|
Enthalten in: |
Carbohydrate polymers - 261(2021) vom: 01. Juni, Seite 117911 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Yen, Chia-Hsiang [VerfasserIn] |
---|
Links: |
---|
Themen: |
9012-76-4 |
---|
Anmerkungen: |
Date Completed 03.05.2021 Date Revised 03.05.2021 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.carbpol.2021.117911 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM323223362 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM323223362 | ||
003 | DE-627 | ||
005 | 20231225183724.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.carbpol.2021.117911 |2 doi | |
028 | 5 | 2 | |a pubmed24n1077.xml |
035 | |a (DE-627)NLM323223362 | ||
035 | |a (NLM)33766385 | ||
035 | |a (PII)S0144-8617(21)00298-8 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Yen, Chia-Hsiang |e verfasserin |4 aut | |
245 | 1 | 0 | |a Cell detachment ratio on pH-responsive chitosan |b A useful biometric for prognostic judgment and drug efficacy assessment in oncology |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 03.05.2021 | ||
500 | |a Date Revised 03.05.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2021 Elsevier Ltd. All rights reserved. | ||
520 | |a The inherently unpredictable complexity of tumors impedes the widespread practice of the molecular biomarkers in outcome prediction. Alternatively, from the biophysical perspective, this study sought to investigate the applicability of the cell detachment ratio (CDR) derived from pH-responsive chitosan as a biometrical identifier for the disease state in cancer prognostic judgment and drug efficacy assessment. In the targeted therapy model, the repression of tumor dissemination in cells harboring aberrant ErbB signals (human non-small cell lung cancer cell line PC9 and breast cancer cell line BT474) were first demonstrated both in vitro and in vivo. Consequently, the corresponding CDR profile goes synchronously with the extent of cancer regression in response to the medication. Definitive integrins that drive the cell detachment were also verified through CDR examination following the integrin functional blockade. Conclusively, CDR is a promising clinical index for evaluation of the metastatic cell behaviors in terms of the cell detachment | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Cell adhesive strength | |
650 | 4 | |a Cell detachment ratio | |
650 | 4 | |a Drug efficacy | |
650 | 4 | |a Integrin | |
650 | 4 | |a Prognosis judgment | |
650 | 4 | |a pH-responsive chitosan | |
650 | 7 | |a Antineoplastic Agents |2 NLM | |
650 | 7 | |a Chitosan |2 NLM | |
650 | 7 | |a 9012-76-4 |2 NLM | |
700 | 1 | |a Young, Tai-Horng |e verfasserin |4 aut | |
700 | 1 | |a Huang, Tsung-Wei |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Carbohydrate polymers |d 1994 |g 261(2021) vom: 01. Juni, Seite 117911 |w (DE-627)NLM082819491 |x 1879-1344 |7 nnns |
773 | 1 | 8 | |g volume:261 |g year:2021 |g day:01 |g month:06 |g pages:117911 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.carbpol.2021.117911 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 261 |j 2021 |b 01 |c 06 |h 117911 |